Why Thermo Fisher Scientific Stock Tumbled Today

Sprawling medical device and solutions company Thermo Fisher Scientific (NYSE: TMO) wasn't looking all that healthy on Tuesday, at least as far as its stock was concerned. The company closed a pair of acquisitions, and the twin moves didn't seem to make some investors happy. As a result, the stock fell by more than 1%, a slightly steeper drop than the S&P 500's (SNPINDEX: ^GSPC) 0.7%. Of Thermo Fisher's two transactions, by far the pricier was its deal for the purification and filtration business of Solventum. It's handing out $4 billion to Solventum, formerly the healthcare business of industrial conglomerate 3M, in an all-cash deal. Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool